CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells

Summary: Localized prostate cancer can be cured by radiation or surgery, but advanced prostate cancer continues to be a clinical challenge. Altered alternative polyadenylation occurs in numerous cancers and can downregulate tumor-suppressor genes and upregulate oncogenes. We found that the cleavage...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiel T. Tietz, Braedan M. McCluskey, Conor R. Miller, Yingming Li, Sarah A. Munro, Scott M. Dehm
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124724015626
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590015705645056
author Kiel T. Tietz
Braedan M. McCluskey
Conor R. Miller
Yingming Li
Sarah A. Munro
Scott M. Dehm
author_facet Kiel T. Tietz
Braedan M. McCluskey
Conor R. Miller
Yingming Li
Sarah A. Munro
Scott M. Dehm
author_sort Kiel T. Tietz
collection DOAJ
description Summary: Localized prostate cancer can be cured by radiation or surgery, but advanced prostate cancer continues to be a clinical challenge. Altered alternative polyadenylation occurs in numerous cancers and can downregulate tumor-suppressor genes and upregulate oncogenes. We found that the cleavage and polyadenylation specificity factor (CPSF) complex factor CPSF1 is upregulated in patients with advanced prostate cancer, with high CPSF1 expression correlating with worse progression-free survival. Knockdown of CPSF1 selectively inhibited the growth of prostate cancer cells and reduced glycolytic output. Evaluating the changes in global poly(A) site usage in prostate cancer cells following CPSF1 knockdown revealed widespread usage of intergenic poly(A) sites distal to annotated 3′ UTRs, which lengthened 3′ UTRs and decreased levels of thousands of mRNAs, including key glycolysis genes. These findings uncover a role for CPSF1 in the suppression of intergenic poly(A) sites in prostate cancer and nominate CPSF1 as a therapeutic target in advanced prostate cancer.
format Article
id doaj-art-e4e69a6eeedc438cb26177958c2f2923
institution Kabale University
issn 2211-1247
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj-art-e4e69a6eeedc438cb26177958c2f29232025-01-24T04:44:59ZengElsevierCell Reports2211-12472025-01-01441115211CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cellsKiel T. Tietz0Braedan M. McCluskey1Conor R. Miller2Yingming Li3Sarah A. Munro4Scott M. Dehm5Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMinnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMinnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA; Corresponding authorSummary: Localized prostate cancer can be cured by radiation or surgery, but advanced prostate cancer continues to be a clinical challenge. Altered alternative polyadenylation occurs in numerous cancers and can downregulate tumor-suppressor genes and upregulate oncogenes. We found that the cleavage and polyadenylation specificity factor (CPSF) complex factor CPSF1 is upregulated in patients with advanced prostate cancer, with high CPSF1 expression correlating with worse progression-free survival. Knockdown of CPSF1 selectively inhibited the growth of prostate cancer cells and reduced glycolytic output. Evaluating the changes in global poly(A) site usage in prostate cancer cells following CPSF1 knockdown revealed widespread usage of intergenic poly(A) sites distal to annotated 3′ UTRs, which lengthened 3′ UTRs and decreased levels of thousands of mRNAs, including key glycolysis genes. These findings uncover a role for CPSF1 in the suppression of intergenic poly(A) sites in prostate cancer and nominate CPSF1 as a therapeutic target in advanced prostate cancer.http://www.sciencedirect.com/science/article/pii/S2211124724015626CP: CancerCP: Molecular biology
spellingShingle Kiel T. Tietz
Braedan M. McCluskey
Conor R. Miller
Yingming Li
Sarah A. Munro
Scott M. Dehm
CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
Cell Reports
CP: Cancer
CP: Molecular biology
title CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
title_full CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
title_fullStr CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
title_full_unstemmed CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
title_short CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
title_sort cpsf1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
topic CP: Cancer
CP: Molecular biology
url http://www.sciencedirect.com/science/article/pii/S2211124724015626
work_keys_str_mv AT kielttietz cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells
AT braedanmmccluskey cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells
AT conorrmiller cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells
AT yingmingli cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells
AT sarahamunro cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells
AT scottmdehm cpsf1inhibitionpromoteswidespreaduseofintergenicpolyadenylationsitesandimpairsglycolysisinprostatecancercells